BenevolentAI
Wlad Stroukov is an Advanced Bioinformatics Data Scientist at BenevolentAI, focusing on drug discovery and precision medicine since February 2023. Simultaneously, Wlad is a candidate in the Wellcome Trust PhD Programme in Immunoregulation at King's College London, working within Prof. Giovanna Lombardi's group. Previous experience includes a role as a Bioinformatics Data Scientist at AstraZeneca, where Wlad contributed to cardiovascular, renal, and metabolic disease research using Knowledge Graphs. Wlad's academic background includes an M.Res. from King's College London and an M.Sc. in Biochemistry and Biophysics from the University of Freiburg, along with extensive research involvement in various renowned laboratories and institutions.
This person is not in any offices
BenevolentAI
8 followers
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, discovering a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.